HSBC Holdings
LENZ

HSBC Holdings’s LENZ Therapeutics LENZ Stock Holding History

HSBC Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
+21,894
New +$308K ﹤0.01% 2606
2024
Q1 		– Sell
-3,124
Closed -$57.7K – 3269
2023
Q4 		$57.7K Buy
3,124
+16
+0.5% +$264 ﹤0.01% 2638
2023
Q3 		$52.2K Buy
+3,108
New +$54K ﹤0.01% 2621

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

HSBC Holdings's LENZ Position: Q1 2026 in Review

HSBC Holdings opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 21,894 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #2606 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in LENZ as recently as Q4 2023.

HSBC Holdings first reported a position in LENZ in Q3 2023 and has held it in 3 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • HSBC Holdings held 21,894 shares of LENZ Therapeutics worth $204K as of Q1 2026.
  • LENZ Therapeutics was a new HSBC Holdings position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2606 holding.
  • HSBC Holdings first reported a position in LENZ Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.